Biomerica, Inc. stock is up 8.79% since 30 days ago. The next earnings date is Jan 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 59.09% of the previous 21 December’s closed higher than November.
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests.